Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,826 | -10,233 | -386 | -38 | -4 |
| Depreciation Amortization | 49 | 11 | 0 | 0 | N/A |
| Accounts receivable | N/A | N/A | 212 | N/A | N/A |
| Accounts payable and accrued liabilities | 567 | 87 | N/A | N/A | N/A |
| Other Working Capital | 8,707 | 306 | 202 | -2 | N/A |
| Other Operating Activity | -282 | 8,005 | -212 | 0 | 0 |
| Operating Cash Flow | $-2,785 | $-1,824 | $-183 | $-40 | $-4 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -423 | -693 | -3 | -3 | N/A |
| Other Investing Activity | -1 | -1,053 | 0 | 0 | 0 |
| Investing Cash Flow | $-424 | $-1,746 | $-3 | $-3 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 150 | 150 | N/A | N/A |
| Common Stock Issued | N/A | 56,741 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 61 | 62 | 43 | 4 |
| Financing Cash Flow | $N/A | $56,952 | $212 | $43 | $4 |
| Beginning Cash Position | 53,382 | N/A | N/A | N/A | N/A |
| End Cash Position | 50,173 | 53,382 | 26 | N/A | N/A |
| Net Cash Flow | $-3,209 | $53,382 | $26 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,785 | -1,824 | -183 | -40 | -4 |
| Capital Expenditure | -423 | -693 | -3 | -3 | N/A |
| Free Cash Flow | -3,208 | -2,517 | -187 | -43 | -4 |